Patrick J McIntire1, Lina Irshaid2, Yifang Liu2, Zhengming Chen3, Faith Menken4, Eugene Nowak4, Sandra J Shin2, Paula S Ginter2. 1. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY. Electronic address: pjm9005@nyp.org. 2. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY. 3. Department of Public Health, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY. 4. Department of Surgery, Weill Cornell Medicine, New York, NY.
Abstract
BACKGROUND: CD8+ tumor-infiltrating lymphocytes (TILs) have emerged as a prognostic indicator in triple-negative breast cancer (TNBC). There is debate surrounding the prognostic value of hot spots for CD8+ TIL enumeration. METHODS: We compared hot spot versus whole-tumor CD8+ TIL enumeration in prognosticating TNBC using immunohistochemistry on whole tissue sections and quantification by digital image analysis (Halo imaging analysis software; Indica Labs, Corrales, NM). A wide range of clinically relevant hot spot sizes was evaluated. RESULTS: CD8+ TIL enumeration was independently statistically significant for all hot spot sizes and whole-tumor annotations for disease-free survival by multivariate analysis. A 10× objective (2.2 mm diameter) hot spot was found to correlate significantly with overall survival (P = .04), while the remaining hot spots and whole-tumor CD8+ TIL enumeration did not (P > .05). Statistical significance was not demonstrated when comparing between hot spots and whole-tumor annotations, as the groups had overlapping confidence intervals. CONCLUSION: CD8+ TIL hot spot enumeration is equivalent to whole-tumor enumeration for prognostication in TNBC and may serve as a good alternative methodology in future studies and clinical practice.
BACKGROUND:CD8+ tumor-infiltrating lymphocytes (TILs) have emerged as a prognostic indicator in triple-negative breast cancer (TNBC). There is debate surrounding the prognostic value of hot spots for CD8+ TIL enumeration. METHODS: We compared hot spot versus whole-tumorCD8+ TIL enumeration in prognosticating TNBC using immunohistochemistry on whole tissue sections and quantification by digital image analysis (Halo imaging analysis software; Indica Labs, Corrales, NM). A wide range of clinically relevant hot spot sizes was evaluated. RESULTS:CD8+ TIL enumeration was independently statistically significant for all hot spot sizes and whole-tumor annotations for disease-free survival by multivariate analysis. A 10× objective (2.2 mm diameter) hot spot was found to correlate significantly with overall survival (P = .04), while the remaining hot spots and whole-tumorCD8+ TIL enumeration did not (P > .05). Statistical significance was not demonstrated when comparing between hot spots and whole-tumor annotations, as the groups had overlapping confidence intervals. CONCLUSION:CD8+ TIL hot spot enumeration is equivalent to whole-tumor enumeration for prognostication in TNBC and may serve as a good alternative methodology in future studies and clinical practice.
Authors: Marylène Lejeune; Benoît Plancoulaine; Nicolas Elie; Ramon Bosch; Laia Fontoura; Izar de Villasante; Anna Korzyńska; Andrea Gras Navarro; Esther Sauras Colón; Carlos López Journal: Histochem Cell Biol Date: 2021-08-12 Impact factor: 4.304
Authors: You Jeong Heo; Taebum Lee; Sun-Ju Byeon; Eun Ji Kim; Hyeong Chan Shin; Binnari Kim; So Young Kang; Sang Yun Ha; Kyoung-Mee Kim Journal: J Pathol Clin Res Date: 2020-09-04
Authors: Siwen Xu; Zixiao Lu; Wei Shao; Christina Y Yu; Jill L Reiter; Qianjin Feng; Weixing Feng; Kun Huang; Yunlong Liu Journal: BMC Med Genomics Date: 2020-12-28 Impact factor: 3.063